VeriSIM Life
VeriSIM Life is an AI-driven drug discovery and development company that applies mechanistic artificial intelligence and quantitative simulation to reduce the cost, time, and failure rate of translating drug candidates into clinical trials. Its BIOiSIM platform is a biosimulation decision engine that can screen large libraries of drug-like compounds and run simulation scenarios across species and dosing regimens, while AtlasGEN designs novel molecules and evaluates them for safety and efficacy. The company operates PulmoSIM Therapeutics as a subsidiary. VeriSIM Life exposes no public developer API, SDK, or developer portal; the platform is accessed through partnerships and demos. This profile is maintained in the API Evangelist network for discovery and monitoring.
VeriSIM Life is profiled on the APIs.io network. Tagged areas include Company, Digital Biology, Drug Discovery, Artificial Intelligence, and Life Sciences.
VeriSIM Life’s developer surface includes engineering blog, support, and 4 more developer resources.
Kin Score
Security Posture 1
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Build 1
SDKs, sample code, and the tooling you integrate with
Access & Security 1
Authentication, authorization, and security posture
Operate 1
Status, limits, changes, and where to get help
Commercial 1
Pricing, plans, and the legal terms of use
Company 2
The organization behind the API